Comparison of a polyethylene glycol membrane and a collagen membrane for the treatment of bone dehiscence defects

Comparison of a polyethylene glycol membrane and a collagen membrane for the treatment of bone dehiscence defects at bone level implants—A prospective, randomized, controlled, multicenter clinical trial
The aim of the present randomized, controlled clinical multicenter trial was to compare a polyethylene glycol (PEG) and a native collagen membrane (BG) for simultaneous guided bone regeneration at bony dehiscence‐type defects around bone level titanium implants.

Material and methods

The study enrolled 117 patients requiring implant treatment in the posterior maxilla or mandible with expected buccal bony dehiscence‐type defects at the placed titanium implants. According to a parallel groups design, defects were filled with a synthetic bone filler and randomly assigned to either PEG or BG membrane.

Both membranes supported bone regeneration at dehiscence‐type defects and obtained vertical bone fill with a relative change in defect height of 59.7% (PEG) and 64.4% (BG); however, the non‐inferiority of PEG could not be shown.
Author(s) Source
Jung RE, Mihatovic I, Cordaro L, Windisch P, Friedmann A, Carrion JB, Sanchez IS, Hallman M, Quirynen M, Hammerle ChHF
Clinical Oral Implant Research, 02.09.2020,  
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. The content usually is shortened to make it understandable for many. Read the linked original text if you are interested. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know

Leave a Reply

Your email address will not be published. Required fields are marked *